11/19
09:14 am
xfor
Biopharma Leaders of Color (BLOC) Announces Board of Directors and Establishes Executive Council to Expand and Enhance Offerings [Yahoo! Finance]
Low
Report
Biopharma Leaders of Color (BLOC) Announces Board of Directors and Establishes Executive Council to Expand and Enhance Offerings [Yahoo! Finance]
11/14
01:34 pm
xfor
X4 Pharmaceuticals, Inc. (NASDAQ: XFOR) had its price target lowered by analysts at HC Wainwright from $5.00 to $1.50. They now have a "buy" rating on the stock.
High
Report
X4 Pharmaceuticals, Inc. (NASDAQ: XFOR) had its price target lowered by analysts at HC Wainwright from $5.00 to $1.50. They now have a "buy" rating on the stock.
11/14
08:15 am
xfor
X4 Pharmaceuticals, Inc. (NASDAQ: XFOR) had its price target lowered by analysts at Stifel Nicolaus from $5.00 to $4.00. They now have a "buy" rating on the stock.
High
Report
X4 Pharmaceuticals, Inc. (NASDAQ: XFOR) had its price target lowered by analysts at Stifel Nicolaus from $5.00 to $4.00. They now have a "buy" rating on the stock.
11/14
08:12 am
xfor
X4 Pharmaceuticals to Participate in the Stifel 2024 Healthcare Conference [Yahoo! Finance]
High
Report
X4 Pharmaceuticals to Participate in the Stifel 2024 Healthcare Conference [Yahoo! Finance]
11/14
08:00 am
xfor
X4 Pharmaceuticals to Participate in the Stifel 2024 Healthcare Conference
High
Report
X4 Pharmaceuticals to Participate in the Stifel 2024 Healthcare Conference
11/14
02:21 am
xfor
X4 Pharmaceuticals Inc (XFOR) Q3 2024 Earnings Call Highlights: Strategic Engagement and ... [Yahoo! Finance]
High
Report
X4 Pharmaceuticals Inc (XFOR) Q3 2024 Earnings Call Highlights: Strategic Engagement and ... [Yahoo! Finance]
11/13
06:16 am
xfor
X4 Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
High
Report
X4 Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
11/13
06:07 am
xfor
X4 Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Update
High
Report
X4 Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Update
11/13
06:05 am
xfor
X4 Pharmaceuticals Announces Positive Results from Completed Six-Month Phase 2 Trial of Mavorixafor in Chronic Neutropenia (CN) [Yahoo! Finance]
High
Report
X4 Pharmaceuticals Announces Positive Results from Completed Six-Month Phase 2 Trial of Mavorixafor in Chronic Neutropenia (CN) [Yahoo! Finance]
11/13
06:01 am
xfor
X4 Pharmaceuticals Announces Positive Results from Completed Six-Month Phase 2 Trial of Mavorixafor in Chronic Neutropenia (CN)
High
Report
X4 Pharmaceuticals Announces Positive Results from Completed Six-Month Phase 2 Trial of Mavorixafor in Chronic Neutropenia (CN)
11/7
11:59 am
xfor
The people-first approach transforming eClinical processes [Yahoo! Finance]
Medium
Report
The people-first approach transforming eClinical processes [Yahoo! Finance]
11/1
04:05 pm
xfor
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10/24
08:00 am
xfor
X4 Pharmaceuticals to Report Third-Quarter 2024 Financial and Phase 2 Chronic Neutropenia Study Results During Conference Call and Webcast on November 13, 2024
Medium
Report
X4 Pharmaceuticals to Report Third-Quarter 2024 Financial and Phase 2 Chronic Neutropenia Study Results During Conference Call and Webcast on November 13, 2024
10/1
04:05 pm
xfor
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
9/18
11:17 am
xfor
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) is a favorite amongst institutional investors who own 51% [Yahoo! Finance]
Low
Report
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) is a favorite amongst institutional investors who own 51% [Yahoo! Finance]
9/3
04:05 pm
xfor
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
8/28
08:00 am
xfor
X4 Pharmaceuticals to Participate in Upcoming September Investor Conferences
Low
Report
X4 Pharmaceuticals to Participate in Upcoming September Investor Conferences